Palantir Technologies stands at the intersection of AI adoption and valuation concerns. The company continues to post exceptional revenue growth while trading at premium multiples that divide Wall Street analysts.
Palantir's AI-powered platform has become a central operating system for Western institutions, driving accelerating growth in both commercial and government sectors.
In Q4 2025, revenue reached $1.407 billion, a 70% year-over-year increase. Over the last twelve months, revenue growth hit 68%, with gross profit margins of 84%.
The U.S. market grew 93% year-over-year, with commercial revenue accelerating to triple-digit growth rates (121% in Q3 2025).
For FY2026, management guided revenue between $7.182B and $7.198B, with adjusted free cash flow of $3.925B to $4.125B.
The Artificial Intelligence Platform (AIP) is the primary catalyst for commercial expansion. It connects data with applications to drive measurable outcomes, differentiating Palantir in an environment where 95% of organizations see no return from AI.
Government revenue grew 43-55% annually, with U.S. federal contracts increasing about 20%. Long-term relationships with defense and intelligence agencies provide recurring revenue.
Palantir trades at 50-90 times forward revenue, well above software industry averages. While the P/E ratio is 154, the PEG ratio of 0.5 suggests valuation may be reasonable relative to growth.
Some analysts argue improved free cash flow projections support the valuation, while skeptics note that multiples leave no room for missteps.
The company achieved debt-free status in 2022 and expects cash reserves of $8.4B by FY2025.
With only 2.4% penetration of its total addressable market, Palantir has significant growth runway in healthcare, energy, manufacturing, and financial services.
Partnerships with Oracle and Snowflake provide distribution advantages. Competition is intensifying, but Palantir's integration capabilities and proven results create a competitive moat.
International expansion faces regulatory hurdles, but the UK Armed Forces deal shows potential beyond the U.S.
Investors must weigh the company's strong growth and market position against its elevated valuation and execution risks.
